Company: CRL
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001100682-25-000043
Chunk: 31

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-11-05
Form: 10-Q
Item: Item 2
Chunk 31
---
,510 11.0 %Total revenue$1,004,852 $1,009,763 $(4,911)(0.5)%

Three Months EndedSeptember 27, 2025September 28, 2024$ change% changeImpact of FX(in thousands, except percentages)RMS$213,474 $197,824 $15,650 7.9 %1.4 %DSA600,685 615,060 (14,375)(2.3)%1.2 %Manufacturing190,693 196,879 (6,186)(3.1)%2.0 %Total revenue$1,004,852 $1,009,763 $(4,911)(0.5)%1.3 %

The following table presents operating income by reportable segment:

Three Months EndedSeptember 27, 2025September 28, 2024$ change% changeImpact of FX(in thousands, except percentages)RMS$34,553 $27,544 $7,009 25.4 %3.6 %DSA123,153 126,436 (3,283)(2.6)%0.8 %Manufacturing39,926 40,188 (262)(0.7)%2.7 %Unallocated corporate(63,833)(76,763)12,930 (16.8)%0.5 %Total operating income$133,799 $117,405 $16,394 14.0 %2.4 %Operating income % of revenue13.3 %11.6 %170 bps

The following presents and discusses our consolidated financial results by each of our reportable segments:

RMS

Three Months EndedSeptember 27, 2025September 28, 2024$ change% changeImpact of FX(in thousands, except percentages)Revenue$213,474 $197,824 $15,650 7.9 %1.4 %Cost of revenue (excluding amortization of intangible assets)148,004 137,906 10,098 7.3 %Selling, general and administrative24,934 26,453 (1,519)(5.7)%Amortization of intangible assets5,983 5,921 62 1.0 %Operating income$34,553 $27